ORIGINAL RESEARCH
Accepted on 12 Mar 2025
The Role of Transketolase in the Immunotherapy and Prognosis of Hepatocellular Carcinoma: A Multi-Omics Approach
doi 10.3389/fimmu.2025.1529029
- Frontiers in Surgery
- Surgical Oncology
- Research Topics
- Frontier Developments in Immunotherapy for Hepatocellular Carcinoma
Frontier Developments in Immunotherapy for Hepatocellular Carcinoma
884
Total downloads
3,005
Total views and downloads
Articles
CASE REPORT
Published on 11 Mar 2025
Case Report: A rare small bowel sarcoma
doi 10.3389/fsurg.2025.1456485
- 176 views
ORIGINAL RESEARCH
Published on 22 Oct 2024
Safety and efficacy of DEB-TACE in combination with lenvatinib and camrelizumab for the treatment of unresectable hepatocellular carcinoma (uHCC): a two-centre retrospective study
doi 10.3389/fimmu.2024.1422784
- 810 views
ORIGINAL RESEARCH
Published on 07 Aug 2024
Postoperative adjuvant immunotherapy and molecular targeted therapy for patients of hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy: a propensity score matching study
doi 10.3389/fsurg.2024.1387246
- 717 views
Published in
Frontiers in Surgery
Surgical Oncology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore